Columbus VP closes its fourth 150 million fund aimed at developing biotech startups

by Columbus Venture Partners

Columbus Venture Partners (VP) has closed on Tuesday its fourth investment fund with a size of 150 million euros for startups in the biotechnology and pharmaceutical sector, while the total amount of ...

Read more

Multiverse Computing Raises Oversubscribed €25 million Series A Investment Round to Advance Quantum and Quantum-Inspired Computing Software

by Colombus Venture Partners

The round was led by Columbus Venture Partners through their SCR, with significant contributions from Quantonation Ventures and new investors, including the European Innovation Council Fund, Redstone ...

Read more

ARTHEx Biotech, backed by Columbus Venture Partners, receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

by Columbus Venture Partners

ARTHEx Biotech has announced that the U.S. Food and Drug Administration (FDA) cleared the Company to initiate the Phase I-IIa ArthemiR™ study of ATX-01 for the treatment of Myotonic Dystrophy Type 1...

Read more

MONDRAGON, Columbus Venture Partners y Cleon Capital lideran una ronda de €2 millones en Cocoon Bioscience

by MONDRAGON Centro de Promoción Empresarial

Cocoon Bioscience ha levantado €2 millones en una ronda de inversión liderada por MONDRAGON, Bexen Medical, Columbus Venture Partners y Cleon Capital, y que ha incluido a su vez a Viscofan, la esta...

Read more

Quatre Lab, backed by Columbus Venture Partners and Grupo SPRI, establishes itself in the Gipuzkoa Science and Technology Park

by Columbus Venture Partners

The investors behind QUATRE LAB include Columbus Venture Partners through its Columbus Life Sciences Fund III and Gestión de Capital Riesgo del País Vasco, SGEIC, S.A. – Grupo SPRI, through its ma...

Read more

ARTHEx Biotech Announces Closing of €42 M Series B Financing led by Columbus Venture Partners to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1)

by Columbus Venture Partners

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs announced the closing of its €42 million Series B financing...

Read more

Columbus Life Sciences Fund IV, with a size of EUR 150 million, has been recently incorporated and accepted by the CNMV

by Columbus Venture Partners

Columbus Life Sciences Fund IV has been recently incorporated and accepted by the CNMV. CVP's fund IV will have a size of EUR 150 million and will follow the same strategy as the previous funds. 10 - ...

Read more

Cocoon Bioscience announces closing of a €15M funding round led by Columbus Venture Partners and Cleon Capital to scale high value proteins production

by Columbus Venture Partners

Cocoon Bioscience’s funding round, led by Columbus Venture Partners and Cleon Capital, will also include several blue-chip co-investors including the Spanish listed company Viscofan, US-based North ...

Read more

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe

by Columbus Venture Partners

Minoryx is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chies...

Read more

Cleon Capital and Columbus Venture Partners announce the divestment of Spanish biotech company Algenex

by Columbus Venture Partners

The shareholders of Algenex, a privately held biotechnology company backed by a group of families advised by Cleon Capital and leading Spanish biotech fund Columbus Venture Partners, today announced a...

Read more

Minoryx raises €51 million in a round co-led by Columbus Venture Partners and Caixa Capital Risc to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

by Caixa Capital Risc

The round was co-led by Columbus Venture Partners and Caixa Capital Risc. Dr. Damià Tormo, representing Columbus Venture Partners, has joined Minoryx’s Board of Directors. CDTI, through its Innvier...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Redarbor, con el apoyo de Vitruvian Part...

by Professional Newco

Redarbor ha financiado la operación a través de una inversión del f...

Photos Stream